Outcomes of Cerebral Embolic Protection for Bicuspid Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Replacement - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37301750/
Background There was limited high-quality evidence that illuminated the efficiency of cerebral embolic protection (CEP) use during transcatheter aortic valve replacement (TAVR) for bicuspid aortic valve (BAV) stenosis. Methods and...
Conclusions: This observational study supported CEP use for BAV stenosis, which was independently associated with less in‐hospital stroke without burdening the patients with a high hospitalization cost.
Comparison of Outcomes Following Transcatheter Aortic Valve Replacement Requiring Peripheral Vascular Intervention or Alternative Access - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37301759/
Background Peripheral vascular intervention (PVI) is occasionally required to facilitate delivery system insertion or to treat vascular complications during transfemoral transcatheter aortic valve replacement (TF-TAVR). However, the impact of PVI...
Conclusions: The need for PVI during TF‐TAVR is not uncommon, mainly due to the bailout treatment for vascular complications. PVI is not associated with worse outcomes in TF‐TAVR recipients. Even when PVI is required, TF‐TAVR is associated with better short‐ and intermediate‐term outcomes than non‐TF‐TAVR.
Open-Heart Cardio-Thoracic Biological Valve Replacement Following Complicated Transcatheter Aortic Valve Implantation - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37241008/
Transcatheter aortic valve implantation (TAVI) is currently becoming the method of choice in high-risk patients with severe aortic valve stenosis. Post-TAVI complications are more common owing to the increasing use...
Conclusions/Relevance: Introduction of new interventional treatment approaches and the availability of imaging tools have substantially reduced the incidence of significant paravalvular leak and offered a better prognosis for patients undergoing TAVI.
-
Aortic Stenosis Connect3yrKey Points • Source: Journal of Personalized Medicine • Conclusions/Relevance: “We present the case report of an 81-year-old patient admitted to our hospital because of exacerbation of the clinical condition and development of pulmonary Show More
Conclusions/Relevance: We report a case of TAVR using BEV in a long-term corticosteroid user that resulted in annular rupture and subsequent surgical repair. Considering tissue fragility in corticosteroid users, careful balloon dilation may be necessary when using BEV.
The Positive Impact of Early Frailty Levels on Mortality in Elderly Patients with Severe Aortic Stenosis Undergoing Transcatheter/Surgical Aortic Valve Replacement - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37233180/
Background: Frailty is highly common in older patients (pts) undergoing transcatheter aortic valve replacement (TAVR), and it is associated with poor outcomes. The selection of patients who can benefit from...
Conclusions: According to tailored frailty management, elderly AS pts with early frailty levels seem to be the most suitable candidates for TAVR/SAVR for positive outcomes because advanced frailty would make each treatment futile or palliative.